Published in Journal of the American College of Surgeons · View the paper (DOI)
A new study from the American College of Surgeons found that longer time to surgical treatment does not lower overall survival for women with early-stage breast cancer who underwent delayed operations before the pandemic. Patients who received neoadjuvant endocrine therapy also showed no decreased survival, according to the research.
Coverage from 2 institutions